Molecular characterization and antigenic prediction of foot-and- mouth disease virus in relation to vaccine improvement in endemic settings in Africa

Loading...
Thumbnail Image

Date

2024-05

Journal Title

Journal ISSN

Volume Title

Publisher

Sokoine University of Agriculture

Abstract

Foot-and-mouth disease (FMD) affects all cloven-hoofed livestock and wildlife, and it is caused by FMD virus (FMDV) that belongs to the genus Aphthorvirus and family Picornaviridae. The disease threatens food security and livelihoods across different parts of the world. There are seven FMDV serotypes (O, A, C, Asia1, SAT1-3), and studies in southern Africa describe buffalos to be persistently infected reservoirs of SATs and transmit the viruses to cattle. The FMD control is challenging and antigenic heterogeneity among field-circulating strains represents the most significant factor. The field's infinite variants pose a challenge to the effectiveness of vaccines and suggests for quick, reliable, and cost-effective methods for obtaining vaccine improvements relevant information timely. FMD is endemic in Africa; impacting the livelihoods of pastoral communities, and hinders the livestock sector by denying access of regional and global lucrative markets. Currently, the strategies deployed to control FMD in Africa, especially tropical Africa, are typically fragmented national-level focused activities with relatively poor outcomes, rather than regionally coordinated initiatives that have been used on other continents (South America, Europe) to reduce and even eliminate virus circulation. Studies have not demonstrated whether the buffalo can also act as carrier of the EurAsian serotypes O and A occurring in parts of East Africa. Also the current epidemiological status of the field circulating strains and their genetic-antigenic characteristics need to be understood. Also, it was unclear on the main challenges to FMD control under pastoral dominated and endemic settings in Africa that has hindered FMD control for decades. This study investigated field reported outbreaks and clinically health buffalo of Tanzania to determine the molecular epidemiology of the circulating field strains between 2018 and 2021, their genetic- antigenic characteristics, and their evolutionary relationships using molecular techniques for FMDV detection, typing, and characterization. The seroprevalence of FMDV serotypes O and A in Tanzania were studied using NSP ELISA for natural infection screening and typed by Solid phase competitive ELISA (SPCE) assay. Additionally; the B-cell antigenic epitopes of SAT1 types were mapped by combined publicly available immuno-informatics tools ranging from those employing propensity scales to the most recent machine learning and artificial intelligence models, to maximize the prediction authenticity, on the FMDV type SAT1 VP1 polypeptides from this study and those sourced from global rich databases. The study identified three FMDV serotypes (A, O and, SAT1) circulating in the field as Africa Topotype G-I lineage, EA-2 Topotype, and Topotype I (NWZ) respectively. This study nucleotide sequences for serotypes O and SAT1 field strains were analysed categorically, and the shared percent identities of 92.0-100.0% and 96.9-98.8% were revealed respectively. The analysed 247 buffalo (37.6%, n =93) and cattle (58.3%, n =154) NSP ELISA positive serum samples from livestock-wildlife interface areas of Katavi, Mikumi, Mkomazi, and Ruaha ecosystems in Tanzania were further analyzed for FMDV serotype O and A by SPCE. A highest percentage seropositivity (PS) was revealed (67%, n= 103) and (55%, n= 51) in cattle and buffalo, whereas FMDV serotype A tested highest (54%, n= 83) and O (25%, n= 23) for cattle and buffalo sera, respectively. Also, some of the cattle (36%, n= 56) and buffalo (25%, n= 23) sera tested, showed evidence of multiple infection with FMDV serotypes O and A. Results showed that out of the 93 analyzed NSPE positive buffalo samples, 30.1% (28) of CI (19 – 39) had antibodies specific to FMDV Type A. Also 54.8% (51) of CI (39 – 64) and 24.7% (23) of CI (15 – 33) had antibodies specific to FMDV type O and those of mixed sero reaction respectively. Similarly, out of 154 NSPE positive cattle samples analyzed 53.9% (83) of CI (69 – 98), 66.9% (103) of CI (88 – 118) and 36.4% (56) of CI (44 – 70) had FMDV antibodies specific to type A, O, and mixed (O&A) seroreactions respectively. The results of compared serotype-specific seroreactions statuses revealed higher percentage for type O across all species, next type A, and the lowest score for mixed seroreactions. Similarly; at 95% CI, the analyzed cattle and buffalo NSPE positives expressed higher scores of (41.7%; 20.65%) by (33.6%; 11.34%) and (22.67%; 9.31%) on type O, type A and mixed seroreactions respectively. Results on Chi-square test of independence were significant, X2 (df = 4, N = 330) = 31.0876, p =.00001 at p<.05 criteria, indicating a relation between spp difference and variation in state of FMDV infection rates. The analyzed probang buffalo samples (n=89) from Serengeti national park using FMDV serotype O and A specific primers (one-step RT-PCR), 1.2% was revealed to be FMDV type O. Also, five consensus linear epitopes (PLE I – V) at positions 3-30, 44-59, 95-112, 134-149, 199-219 with 75%, 88%, 94%, 44 % and 24% of their aa reads conserved were observed respectively. Additionally; conformational epitopes (PCE I – VI) at positions 1-26, 82-87, 93-114, 131-149, 175-179, and 201-221 with 53 – 100% conserved were also identified. As the vaccines are challenged by the rapidly evolving FMDV in the field, the unveiling of conserved epitope domains is vital for enhancing future FMDV vaccines long-term effectiveness in the field. This study has demonstrated FMDV type O infections in buffalo being the first molecular and serosurvey combined study to be undertaken on Eurasian FMDV types O and A in cattle and buffalos in Tanzania. The information generated from this study strengthens knowledge on FMDV epidemiology in Tanzania and Africa, and thereby contributing to the progressive control pathway-FMD program through tailored control initiatives. The unveiled challenges of FMD control amongst Africa’s diverse pastoral communities’ landscape for triggering strategical discussions on national and transboundary regional-based FMD control approaches in Africa.

Description

PhD Thesis

Keywords

Molecular Characterization, Antigenic Prediction, Mouth Disease Virus, Vaccine Improvement -Endemic Settings, Africa

Citation